Circulating tumor HPV DNA in the management of HPV+ oropharyngeal cancer and its correlation with MRI
Background First aim was to compare ddPCR assays of ctHPVDNA with p16 IHC and qualitative HPV PCR. Second aim was to carry out longitudinal blood sampling to test for association of ctHPVDNA with histological confirmed recurrence. Third aim was to perform a multidimensional assessment which included...
Saved in:
| Published in: | Head & neck Vol. 46; no. 9; pp. 2206 - 2213 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Hoboken, USA
John Wiley & Sons, Inc
01-09-2024
Wiley Subscription Services, Inc |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
First aim was to compare ddPCR assays of ctHPVDNA with p16 IHC and qualitative HPV PCR. Second aim was to carry out longitudinal blood sampling to test for association of ctHPVDNA with histological confirmed recurrence. Third aim was to perform a multidimensional assessment which included: (1) clinical features; (2) ctHPVDNA; (3) MRI‐based tumor size measurements of primary tumor (PT) and cervical lymph node metastases (CLNM).
Methods
Plasma samples were collected before treatment and during follow‐up, and ddPCR assay comprising E6 of HPV16 and HPV 33 and HPV 35 was used.
Results
Present study was conducted at diagnosis in 117 patients and revealed a ctHPVDNA sensitivity of 100% (95% CI 95.5–100) and a specificity of 94.4 (95% CI 81.3–99.3), positive predictive value (PPV) of 94.4 (95% CI 81.3–99.3), and negative predictive value (NPP) of 100% (95% CI 89.7–100). During follow‐up ctHPVDNA had a sensitivity of 100% (95% CI 72.1–100)% and specificity of 98.4% (95% CI 91.7–100)%, PPV% of 90.9% (95% CI 62.3–98.4) and NPV% of 100% (95% CI 94.3–100) for ability to detect recurrence. Correlation between both the CLNM volume and the sum of PT and CLNM volume was observed.
Conclusions
ctHPVDNA was superior to p16 in identification of HPV‐OPSCC at diagnosis. Introduction of ctHPVDNA, beyond diagnostic setting, represents a great opportunity to improve follow‐up protocol of OPSCC patients. |
|---|---|
| AbstractList | Background
First aim was to compare ddPCR assays of ctHPVDNA with p16 IHC and qualitative HPV PCR. Second aim was to carry out longitudinal blood sampling to test for association of ctHPVDNA with histological confirmed recurrence. Third aim was to perform a multidimensional assessment which included: (1) clinical features; (2) ctHPVDNA; (3) MRI‐based tumor size measurements of primary tumor (PT) and cervical lymph node metastases (CLNM).
Methods
Plasma samples were collected before treatment and during follow‐up, and ddPCR assay comprising E6 of HPV16 and HPV 33 and HPV 35 was used.
Results
Present study was conducted at diagnosis in 117 patients and revealed a ctHPVDNA sensitivity of 100% (95% CI 95.5–100) and a specificity of 94.4 (95% CI 81.3–99.3), positive predictive value (PPV) of 94.4 (95% CI 81.3–99.3), and negative predictive value (NPP) of 100% (95% CI 89.7–100). During follow‐up ctHPVDNA had a sensitivity of 100% (95% CI 72.1–100)% and specificity of 98.4% (95% CI 91.7–100)%, PPV% of 90.9% (95% CI 62.3–98.4) and NPV% of 100% (95% CI 94.3–100) for ability to detect recurrence. Correlation between both the CLNM volume and the sum of PT and CLNM volume was observed.
Conclusions
ctHPVDNA was superior to p16 in identification of HPV‐OPSCC at diagnosis. Introduction of ctHPVDNA, beyond diagnostic setting, represents a great opportunity to improve follow‐up protocol of OPSCC patients. First aim was to compare ddPCR assays of ctHPVDNA with p16 IHC and qualitative HPV PCR. Second aim was to carry out longitudinal blood sampling to test for association of ctHPVDNA with histological confirmed recurrence. Third aim was to perform a multidimensional assessment which included: (1) clinical features; (2) ctHPVDNA; (3) MRI-based tumor size measurements of primary tumor (PT) and cervical lymph node metastases (CLNM). Plasma samples were collected before treatment and during follow-up, and ddPCR assay comprising E6 of HPV16 and HPV 33 and HPV 35 was used. Present study was conducted at diagnosis in 117 patients and revealed a ctHPVDNA sensitivity of 100% (95% CI 95.5-100) and a specificity of 94.4 (95% CI 81.3-99.3), positive predictive value (PPV) of 94.4 (95% CI 81.3-99.3), and negative predictive value (NPP) of 100% (95% CI 89.7-100). During follow-up ctHPVDNA had a sensitivity of 100% (95% CI 72.1-100)% and specificity of 98.4% (95% CI 91.7-100)%, PPV% of 90.9% (95% CI 62.3-98.4) and NPV% of 100% (95% CI 94.3-100) for ability to detect recurrence. Correlation between both the CLNM volume and the sum of PT and CLNM volume was observed. ctHPVDNA was superior to p16 in identification of HPV-OPSCC at diagnosis. Introduction of ctHPVDNA, beyond diagnostic setting, represents a great opportunity to improve follow-up protocol of OPSCC patients. BackgroundFirst aim was to compare ddPCR assays of ctHPVDNA with p16 IHC and qualitative HPV PCR. Second aim was to carry out longitudinal blood sampling to test for association of ctHPVDNA with histological confirmed recurrence. Third aim was to perform a multidimensional assessment which included: (1) clinical features; (2) ctHPVDNA; (3) MRI‐based tumor size measurements of primary tumor (PT) and cervical lymph node metastases (CLNM).MethodsPlasma samples were collected before treatment and during follow‐up, and ddPCR assay comprising E6 of HPV16 and HPV 33 and HPV 35 was used.ResultsPresent study was conducted at diagnosis in 117 patients and revealed a ctHPVDNA sensitivity of 100% (95% CI 95.5–100) and a specificity of 94.4 (95% CI 81.3–99.3), positive predictive value (PPV) of 94.4 (95% CI 81.3–99.3), and negative predictive value (NPP) of 100% (95% CI 89.7–100). During follow‐up ctHPVDNA had a sensitivity of 100% (95% CI 72.1–100)% and specificity of 98.4% (95% CI 91.7–100)%, PPV% of 90.9% (95% CI 62.3–98.4) and NPV% of 100% (95% CI 94.3–100) for ability to detect recurrence. Correlation between both the CLNM volume and the sum of PT and CLNM volume was observed.ConclusionsctHPVDNA was superior to p16 in identification of HPV‐OPSCC at diagnosis. Introduction of ctHPVDNA, beyond diagnostic setting, represents a great opportunity to improve follow‐up protocol of OPSCC patients. First aim was to compare ddPCR assays of ctHPVDNA with p16 IHC and qualitative HPV PCR. Second aim was to carry out longitudinal blood sampling to test for association of ctHPVDNA with histological confirmed recurrence. Third aim was to perform a multidimensional assessment which included: (1) clinical features; (2) ctHPVDNA; (3) MRI-based tumor size measurements of primary tumor (PT) and cervical lymph node metastases (CLNM).BACKGROUNDFirst aim was to compare ddPCR assays of ctHPVDNA with p16 IHC and qualitative HPV PCR. Second aim was to carry out longitudinal blood sampling to test for association of ctHPVDNA with histological confirmed recurrence. Third aim was to perform a multidimensional assessment which included: (1) clinical features; (2) ctHPVDNA; (3) MRI-based tumor size measurements of primary tumor (PT) and cervical lymph node metastases (CLNM).Plasma samples were collected before treatment and during follow-up, and ddPCR assay comprising E6 of HPV16 and HPV 33 and HPV 35 was used.METHODSPlasma samples were collected before treatment and during follow-up, and ddPCR assay comprising E6 of HPV16 and HPV 33 and HPV 35 was used.Present study was conducted at diagnosis in 117 patients and revealed a ctHPVDNA sensitivity of 100% (95% CI 95.5-100) and a specificity of 94.4 (95% CI 81.3-99.3), positive predictive value (PPV) of 94.4 (95% CI 81.3-99.3), and negative predictive value (NPP) of 100% (95% CI 89.7-100). During follow-up ctHPVDNA had a sensitivity of 100% (95% CI 72.1-100)% and specificity of 98.4% (95% CI 91.7-100)%, PPV% of 90.9% (95% CI 62.3-98.4) and NPV% of 100% (95% CI 94.3-100) for ability to detect recurrence. Correlation between both the CLNM volume and the sum of PT and CLNM volume was observed.RESULTSPresent study was conducted at diagnosis in 117 patients and revealed a ctHPVDNA sensitivity of 100% (95% CI 95.5-100) and a specificity of 94.4 (95% CI 81.3-99.3), positive predictive value (PPV) of 94.4 (95% CI 81.3-99.3), and negative predictive value (NPP) of 100% (95% CI 89.7-100). During follow-up ctHPVDNA had a sensitivity of 100% (95% CI 72.1-100)% and specificity of 98.4% (95% CI 91.7-100)%, PPV% of 90.9% (95% CI 62.3-98.4) and NPV% of 100% (95% CI 94.3-100) for ability to detect recurrence. Correlation between both the CLNM volume and the sum of PT and CLNM volume was observed.ctHPVDNA was superior to p16 in identification of HPV-OPSCC at diagnosis. Introduction of ctHPVDNA, beyond diagnostic setting, represents a great opportunity to improve follow-up protocol of OPSCC patients.CONCLUSIONSctHPVDNA was superior to p16 in identification of HPV-OPSCC at diagnosis. Introduction of ctHPVDNA, beyond diagnostic setting, represents a great opportunity to improve follow-up protocol of OPSCC patients. |
| Author | Moretto, Silvia Pichi, Barbara Campo, Flaminia De Pascale, Valentina Manciocco, Valentina Vidiri, Antonello Ruggiero, Sergio Blandino, Giovanni Marzi, Simona Pellini, Raul Pimpinelli, Fulvia Terrenato, Irene Iocca, Oreste Benevolo, Maria Paolini, Francesca Venuti, Aldo Moretti, Claudio |
| Author_xml | – sequence: 1 givenname: Flaminia orcidid: 0000-0002-9249-7573 surname: Campo fullname: Campo, Flaminia email: flaminia.campo@ifo.it organization: IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO) – sequence: 2 givenname: Francesca surname: Paolini fullname: Paolini, Francesca organization: Sapienza University of Rome – sequence: 3 givenname: Valentina surname: Manciocco fullname: Manciocco, Valentina organization: IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO) – sequence: 4 givenname: Silvia surname: Moretto fullname: Moretto, Silvia organization: IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO) – sequence: 5 givenname: Barbara surname: Pichi fullname: Pichi, Barbara organization: IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO) – sequence: 6 givenname: Claudio surname: Moretti fullname: Moretti, Claudio organization: IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO) – sequence: 7 givenname: Giovanni surname: Blandino fullname: Blandino, Giovanni organization: Istituti Fisioterapici Ospitalieri (IFO) – sequence: 8 givenname: Valentina surname: De Pascale fullname: De Pascale, Valentina organization: Istituti Fisioterapici Ospitalieri (IFO) – sequence: 9 givenname: Maria surname: Benevolo fullname: Benevolo, Maria organization: IRCCS Regina Elena National Cancer Institute – sequence: 10 givenname: Fulvia surname: Pimpinelli fullname: Pimpinelli, Fulvia organization: Istituti Fisioterapici Ospitalieri (IFO) – sequence: 11 givenname: Antonello surname: Vidiri fullname: Vidiri, Antonello organization: Istituti Fisioterapici Ospitalieri (IFO) – sequence: 12 givenname: Simona surname: Marzi fullname: Marzi, Simona organization: Istituti Fisioterapici Ospitalieri (IFO) – sequence: 13 givenname: Sergio surname: Ruggiero fullname: Ruggiero, Sergio organization: Istituti Fisioterapici Ospitalieri (IFO) – sequence: 14 givenname: Irene surname: Terrenato fullname: Terrenato, Irene organization: IRCCS Regina Elena National Cancer Institute – sequence: 15 givenname: Oreste surname: Iocca fullname: Iocca, Oreste organization: University of Torino – sequence: 16 givenname: Aldo surname: Venuti fullname: Venuti, Aldo organization: Istituti Fisioterapici Ospitalieri (IFO) – sequence: 17 givenname: Raul surname: Pellini fullname: Pellini, Raul organization: IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO) |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38979763$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kF1LwzAUQIMofkwf_AMS8EWRbknTNOnj2NQN5geivpYsvd0qbTKTluG_N3PuRfAp4eZwyD0naN9YAwidU9KnhMSDJRT9WMg03UPHlGQiIiwR-5t7wiJGRHKETrz_IISwNIkP0RGTmchEyo4RjCqnu1q1lVngtmusw5Pndzx-HOLK4HYJuFFGLaAB02Jbbh5vsHV2tVTuyyxA1Vgro8FhZQpctR5r6xxshNbgddUu8cPL9BQdlKr2cPZ79tDb3e3raBLNnu6no-Es0pTLNEoTIkupqJaZ5lkxzzhNYi7mBdFkzopSxVyqME9Ac5EAlRQEBypUKYqCyZT10NXWu3L2swPf5k3lNdS1MmA7n4cWgkqRSRbQyz_oh-2cCb8LlMwkTTmPA3W9pbSz3jso85WrmrB6Tkm-aZ-H9vlP-8Be_Bq7eROmO3IXOwCDLbCuavj635RPbsdb5TcggI3g |
| Cites_doi | 10.1158/1078-0432.CCR-21-3151 10.1016/j.oraloncology.2019.08.011 10.1001/jamaoncol.2023.4042 10.3390/cancers15051387 10.1016/j.oraloncology.2018.01.010 10.1016/j.canlet.2012.03.033 10.1002/hed.27515 10.1158/1078-0432.CCR-23-1064 10.1177/00034894211036842 10.1002/hed.24606 10.1038/s41416-019-0414-9 10.1002/hed.27778 10.3390/jcm8020256 10.1002/hed.25425 10.1158/1078-0432.CCR-19-0211 10.1016/j.radonc.2023.109547 10.1186/s13063-023-07881-1 10.1097/CCO.0000000000001029 10.1016/j.ejso.2022.09.016 10.3390/jcm10071525 10.1200/JCO.19.02444 10.1016/j.mri.2012.05.001 10.1038/s41598-021-04307-3 10.1016/j.oraloncology.2022.105870 10.1002/cncy.22497 10.1002/ijc.33798 10.1016/S1470-2045(23)00013-X 10.1002/lary.29739 |
| ContentType | Journal Article |
| Copyright | 2024 The Author(s). published by Wiley Periodicals LLC. 2024 The Author(s). Head & Neck published by Wiley Periodicals LLC. 2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2024 The Author(s). published by Wiley Periodicals LLC. – notice: 2024 The Author(s). Head & Neck published by Wiley Periodicals LLC. – notice: 2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P WIN CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7TK K9. 7X8 |
| DOI | 10.1002/hed.27866 |
| DatabaseName | Wiley-Blackwell Open Access Collection Wiley Online Library Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1097-0347 |
| EndPage | 2213 |
| ExternalDocumentID | 10_1002_hed_27866 38979763 HED27866 |
| Genre | researchArticle Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: MAECI‐Call for Joint Project Proposals Italy‐Brazil funderid: BR22GR03 – fundername: LILT 2020‐21 Program – fundername: MAECI-Call for Joint Project Proposals Italy-Brazil grantid: BR22GR03 – fundername: LILT 2020-21 Program |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 36B 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADZMN ADZOD AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EBD EBS EJD EMB EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V2E W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR X7M XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7QP 7TK K9. 7X8 |
| ID | FETCH-LOGICAL-c1586-6408f8a1c89c59db9514257bd0c0b3dfa258a9db4ec574e181e75e17af7dd3863 |
| IEDL.DBID | 33P |
| ISSN | 1043-3074 1097-0347 |
| IngestDate | Sat Oct 26 04:00:15 EDT 2024 Thu Oct 10 22:18:21 EDT 2024 Fri Nov 22 02:33:02 EST 2024 Sat Nov 02 12:26:20 EDT 2024 Sat Aug 24 00:55:02 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | MRI liquid biopsy human papillomavirus oropharyngeal squamous cell carcinoma circulating tumor DNA |
| Language | English |
| License | Attribution 2024 The Author(s). Head & Neck published by Wiley Periodicals LLC. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c1586-6408f8a1c89c59db9514257bd0c0b3dfa258a9db4ec574e181e75e17af7dd3863 |
| Notes | Flaminia Campo and Francesca Paolini contributed equally to this study. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-9249-7573 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhed.27866 |
| PMID | 38979763 |
| PQID | 3089816552 |
| PQPubID | 996355 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_3077187983 proquest_journals_3089816552 crossref_primary_10_1002_hed_27866 pubmed_primary_38979763 wiley_primary_10_1002_hed_27866_HED27866 |
| PublicationCentury | 2000 |
| PublicationDate | September 2024 2024-09-00 20240901 |
| PublicationDateYYYYMMDD | 2024-09-01 |
| PublicationDate_xml | – month: 09 year: 2024 text: September 2024 |
| PublicationDecade | 2020 |
| PublicationPlace | Hoboken, USA |
| PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Houston |
| PublicationTitle | Head & neck |
| PublicationTitleAlternate | Head Neck |
| PublicationYear | 2024 |
| Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
| References | 2019; 8 2022; 131 2022; 130 2022; 150 2019; 97 2023; 15 2023; 183 2023; 9 2020; 38 2024 2012; 323 2024; 36 2022; 28 2019; 120 2012; 30 2023; 24 2021; 10 2023; 45 2023; 29 2019; 41 2017; 39 2023; 49 2019; 25 2022; 12 2021; 132 2024; 25 2018; 78 2022; 128 39257364 - Head Neck. 2024 Sep 11. doi: 10.1002/hed.27929 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_10_1 e_1_2_8_11_1 e_1_2_8_12_1 |
| References_xml | – volume: 183 year: 2023 article-title: Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT? publication-title: Radiother Oncol – volume: 45 start-page: 2945 year: 2023 end-page: 2954 article-title: It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: systematic review and meta‐analysis publication-title: Head Neck – volume: 30 start-page: 1323 issue: 9 year: 2012 end-page: 1341 article-title: 3D slicer as an image computing platform for the quantitative imaging network publication-title: Magn Reson Imaging – volume: 323 start-page: 88 issue: 1 year: 2012 end-page: 96 article-title: HPV DNA, E6*I‐mRNA expression and p16INK4A immunohistochemistry in head and neck cancer—how valid is p16INK4A as surrogate marker? publication-title: Cancer Lett – volume: 8 issue: 2 year: 2019 article-title: The emerging role of robotic surgery among minimally invasive surgical approaches in the treatment of hypopharyngeal carcinoma: systematic review and meta‐analysis publication-title: J Clin Med – volume: 15 issue: 5 year: 2023 article-title: Predicting response to radical chemoradiotherapy with circulating HPV DNA (cHPV‐DNA) in locally advanced uterine cervix cancer publication-title: Cancers (Basel) – volume: 128 year: 2022 article-title: Long term survival in patients with human papillomavirus‐positive oropharyngeal cancer and equivocal response on 12‐week PET‐CT is not compromised by the omission of neck dissection publication-title: Oral Oncol – volume: 28 start-page: 719 issue: 4 year: 2022 end-page: 727 article-title: Cell‐free HPV DNA provides an accurate and rapid diagnosis of HPV‐associated head and neck cancer publication-title: Clin Cancer Res – volume: 131 start-page: 595 issue: 6 year: 2022 end-page: 603 article-title: Systematic review and meta‐analysis of post‐treatment PET/CT in HPV‐associated oropharyngeal cancer publication-title: Ann Otol Rhinol Laryngol – volume: 150 start-page: 174 issue: 1 year: 2022 end-page: 186 article-title: Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV‐related oropharyngeal cancer and cancer of unknown primary publication-title: Int J Cancer – volume: 41 start-page: 456 issue: 2 year: 2019 end-page: 462 article-title: Posttreatment surveillance PET/CT for HPV‐associated oropharyngeal cancer publication-title: Head Neck – volume: 78 start-page: 137 year: 2018 end-page: 144 article-title: Double positivity for HPV‐DNA/p16(ink4a) is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients publication-title: Oral Oncol – volume: 130 start-page: 12 issue: 1 year: 2022 end-page: 15 article-title: Liquid biopsy for the diagnosis of HPV‐associated head and neck cancer publication-title: Cancer Cytopathol – volume: 25 issue: 1 year: 2024 article-title: CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high‐risk oropharyngeal cancer publication-title: Trials – volume: 10 issue: 7 year: 2021 article-title: Circulating HPV DNA in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives publication-title: J Clin Med – volume: 25 start-page: 4682 issue: 15 year: 2019 end-page: 4690 article-title: Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV‐associated oropharyngeal cancer publication-title: Clin Cancer Res – volume: 29 start-page: 3914 issue: 19 year: 2023 end-page: 3923 article-title: Liquid biopsies with circulating plasma HPV‐DNA measurements—a clinically applicable surveillance tool for patients with HPV‐positive oropharyngeal cancer publication-title: Clin Cancer Res – year: 2024 article-title: Follow‐up for human papillomavirus‐related oropharynx cancer concentrated on unequal symptom change (FOCUS): prospective patient‐reported outcome collection publication-title: Head Neck – volume: 12 issue: 1 year: 2022 article-title: Usefulness of circulating tumor DNA by targeting human papilloma virus‐derived sequences as a biomarker in p16‐positive oropharyngeal cancer publication-title: Sci Rep – volume: 24 start-page: 239 issue: 3 year: 2023 end-page: 251 article-title: Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG‐EPIC‐OPC): a multicentre, multinational, individual patient data analysis publication-title: Lancet Oncol – volume: 120 start-page: 827 issue: 8 year: 2019 end-page: 833 article-title: Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two‐tier approach publication-title: Br J Cancer – volume: 38 start-page: 1050 issue: 10 year: 2020 end-page: 1058 article-title: Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV‐associated oropharyngeal cancer publication-title: J Clin Oncol – volume: 36 start-page: 143 issue: 3 year: 2024 end-page: 146 article-title: Advances in testing for human papillomavirus‐mediated head and neck cancer publication-title: Curr Opin Oncol – volume: 132 start-page: 560 year: 2021 end-page: 568 article-title: Cell‐free human papillomavirus‐DNA for monitoring treatment response of head and neck squamous cell carcinoma: systematic review and meta‐analysis publication-title: Laryngoscope – volume: 49 start-page: 55 issue: 1 year: 2023 end-page: 59 article-title: The role of liquid biopsy in management of the neck with indeterminate response on post‐treatment imaging following non‐surgical management of oropharyngeal cancer publication-title: Eur J Surg Oncol – volume: 9 start-page: 1716 issue: 12 year: 2023 end-page: 1724 article-title: Circulating tumor HPV DNA for surveillance of HPV‐positive oropharyngeal squamous cell carcinoma: a narrative review publication-title: JAMA Oncol – volume: 97 start-page: 76 year: 2019 end-page: 81 article-title: 12 week PET‐CT has low positive predictive value for nodal residual disease in human papillomavirus‐positive oropharyngeal cancers publication-title: Oral Oncol – volume: 39 start-page: 432 issue: 3 year: 2017 end-page: 438 article-title: Earlier and more specific detection of persistent neck disease with diffusion‐weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma publication-title: Head Neck – ident: e_1_2_8_29_1 doi: 10.1158/1078-0432.CCR-21-3151 – ident: e_1_2_8_20_1 doi: 10.1016/j.oraloncology.2019.08.011 – ident: e_1_2_8_11_1 doi: 10.1001/jamaoncol.2023.4042 – ident: e_1_2_8_25_1 doi: 10.3390/cancers15051387 – ident: e_1_2_8_9_1 doi: 10.1016/j.oraloncology.2018.01.010 – ident: e_1_2_8_5_1 doi: 10.1016/j.canlet.2012.03.033 – ident: e_1_2_8_15_1 doi: 10.1002/hed.27515 – ident: e_1_2_8_18_1 doi: 10.1158/1078-0432.CCR-23-1064 – ident: e_1_2_8_23_1 doi: 10.1177/00034894211036842 – ident: e_1_2_8_21_1 doi: 10.1002/hed.24606 – ident: e_1_2_8_7_1 doi: 10.1038/s41416-019-0414-9 – ident: e_1_2_8_28_1 doi: 10.1002/hed.27778 – ident: e_1_2_8_4_1 doi: 10.3390/jcm8020256 – ident: e_1_2_8_19_1 doi: 10.1002/hed.25425 – ident: e_1_2_8_17_1 doi: 10.1158/1078-0432.CCR-19-0211 – ident: e_1_2_8_2_1 doi: 10.1016/j.radonc.2023.109547 – ident: e_1_2_8_3_1 doi: 10.1186/s13063-023-07881-1 – ident: e_1_2_8_8_1 doi: 10.1097/CCO.0000000000001029 – ident: e_1_2_8_26_1 doi: 10.1016/j.ejso.2022.09.016 – ident: e_1_2_8_10_1 doi: 10.3390/jcm10071525 – ident: e_1_2_8_24_1 doi: 10.1200/JCO.19.02444 – ident: e_1_2_8_16_1 doi: 10.1016/j.mri.2012.05.001 – ident: e_1_2_8_13_1 doi: 10.1038/s41598-021-04307-3 – ident: e_1_2_8_22_1 doi: 10.1016/j.oraloncology.2022.105870 – ident: e_1_2_8_14_1 doi: 10.1002/cncy.22497 – ident: e_1_2_8_12_1 doi: 10.1002/ijc.33798 – ident: e_1_2_8_6_1 doi: 10.1016/S1470-2045(23)00013-X – ident: e_1_2_8_27_1 doi: 10.1002/lary.29739 |
| SSID | ssj0003642 |
| Score | 2.4754336 |
| Snippet | Background
First aim was to compare ddPCR assays of ctHPVDNA with p16 IHC and qualitative HPV PCR. Second aim was to carry out longitudinal blood sampling to... First aim was to compare ddPCR assays of ctHPVDNA with p16 IHC and qualitative HPV PCR. Second aim was to carry out longitudinal blood sampling to test for... BackgroundFirst aim was to compare ddPCR assays of ctHPVDNA with p16 IHC and qualitative HPV PCR. Second aim was to carry out longitudinal blood sampling to... |
| SourceID | proquest crossref pubmed wiley |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 2206 |
| SubjectTerms | Adult Aged circulating tumor DNA Circulating Tumor DNA - blood Diagnosis Disease management DNA, Viral - blood Female Human papillomavirus Humans liquid biopsy Lymph nodes Lymphatic Metastasis Magnetic resonance imaging Magnetic Resonance Imaging - methods Male Metastases Middle Aged MRI Neoplasm Recurrence, Local - virology Oropharyngeal cancer Oropharyngeal Neoplasms - blood Oropharyngeal Neoplasms - diagnostic imaging Oropharyngeal Neoplasms - pathology Oropharyngeal Neoplasms - virology oropharyngeal squamous cell carcinoma Papillomavirus Infections - complications Papillomavirus Infections - diagnosis Patients Polymerase Chain Reaction Predictive Value of Tests Sensitivity and Specificity Squamous cell carcinoma Throat cancer Tumors |
| Title | Circulating tumor HPV DNA in the management of HPV+ oropharyngeal cancer and its correlation with MRI |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhed.27866 https://www.ncbi.nlm.nih.gov/pubmed/38979763 https://www.proquest.com/docview/3089816552 https://www.proquest.com/docview/3077187983 |
| Volume | 46 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qyYsPfK0vongQZLXNo0nxtLgr60FZfOGtJGm6uwdb6W7_v5N0WxERBG-lSZkymcl8yUy-IHRGNHG0ao75UcVdlsECJdYuhaiVtgEzofAUG8Mn8fAm-wNHk3PdnIWp-SHaDTfnGX6-dg6u9OzqizR0YtNLImTk6LZhleCPb9BROwvTiNWZTkbd_gprWIUCctV--T0W_QCY3_GqDzi36__61Q20tsCZuFcbxiZasvkWsjfT0vj7uvIxnlfvRYmHo1fcf-jhaY4BCuL3thoGF5lrvMBFWXxMQHY-BkyJjbOSEqs8xdP5DBt3uUddTofdli6-f7zbRi-3g-ebYXdxz0LXhFxG3Qi0l0kVGhkbHqcaQJfzZJ0GJtA0zRThUsF7Zg0XzAImsILbUKhMpCmVEd1BK3mR2z2EqbYQ8DVXDoixyGihRWAYy2RAFGemg04bjScfNZ1GUhMnkwS0lHgtddBhMxbJwqNmCQ1kLMOIc9JBJ20z-IJLcKjcFpXrA5YlRSxpB-3WY9hKAWAmAHpBy7kfqt_FJ8NB3z_s_73rAVolgHbq4rNDtDIvK3uElmdpdezN8hNrBOFR |
| link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7xOJQLBZXCUh6m4lCpWkj8jtQLYhcFASvU0qq3yHYc2AMJyu7-_3qS3SBUISFxizK2JvLMeL6M7c8Ax9RSpFVD5keT9HkRflASi0uI1lgfcRerhmIj_aVGf_VgiDQ5PxZnYVp-iK7ghpHRzNcY4FiQPn1mDX3w-QlVWsplWOUyOCIe4GC33TzMJG_XOjnDCgtf8ApF9LTr-jIb_QcxXyLWJuVcfHzfx27A-hxqkrPWNzZhyZefwJ-Pa9dc2VXek-nssapJevuHDEZnZFySgAbJY7chhlQFCr-Tqq6eHoLy8j7ASuLQUWpiypyMpxPi8H6Pdkcdwaouufl5uQW_L4Z352l_ftVC38VCy77kkS60iZ1OnEhyG3AXBrPNIxdZlheGCm3Ce-6dUNwHWOCV8LEyhcpzpiX7DCtlVfodIMz6kPOtMIjFuHRWWRU5zgsdUSO468HXxZBnTy2jRtZyJ9MsjFLWjFIP9hbGyOZBNclYpBMdSyFoD446cQgHXOMwpa9m2CY4l1aJZj3Ybo3YaQnYTAX0FSTfGlu9rj5Lh4PmYfftTQ_hQ3p3c51dX46uvsAaDeCn3Yu2ByvTeub3YXmSzw4aH_0HthjleQ |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED_WDkZf2o6ubbasU8ceCiOLrQ9LZk-lSXBYG0Lbjb0ZfTnJQ-3gJP9_JTt2KaUw2JvxyZyR7nQ_686_A_iGFfa0ap75UcY9mrkPlFj5FKKSygZUh7yi2Eju-OSvGAw9Tc7P5l-Ymh-iPXDznlHt197BlybrP5GGzq35gbmIoh14Sx0M98T5hEzbbZhEtE51UuIPWGhDKxTgfvvo82D0AmE-B6xVxBkd_Ne7HsL-Fmiiy9oy3sMbmx-BvVqUumrYlc_QevNQlCiZ_kGDySVa5MhhQfTQlsOgIvPC76goi-Xc6c5nDlQi7c2kRDI3aLFeIe27e9T1dMif6aKb2_EH-D0a3l8lvW2jhZ4OmYh6EQ1EJmSoRaxZbJRDXd6VlQl0oIjJJGZCuvvUasapdaDAcmZDLjNuDBEROYbdvMjtKSCirIv4ikmPxGikFVc80JRmIsCSUd2Br82Mp8uaTyOtmZNx6mYprWapA91mLdKtS61SEohYhBFjuAPnrdg5g89wyNwWGz_GmZbgsSAdOKnXsNXikBl32MtJLqqlel19mgwH1cXHfx_6Bd5NB6P0ejz59Qn2sEM-dSFaF3bX5cZ-hp2V2ZxVFvoI_PzkHw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circulating+tumor+HPV+DNA+in+the+management+of+HPV%2B+oropharyngeal+cancer+and+its+correlation+with+MRI&rft.jtitle=Head+%26+neck&rft.au=Campo%2C+Flaminia&rft.au=Paolini%2C+Francesca&rft.au=Manciocco%2C+Valentina&rft.au=Moretto%2C+Silvia&rft.date=2024-09-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1043-3074&rft.eissn=1097-0347&rft.volume=46&rft.issue=9&rft.spage=2206&rft.epage=2213&rft_id=info:doi/10.1002%2Fhed.27866&rft.externalDBID=10.1002%252Fhed.27866&rft.externalDocID=HED27866 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-3074&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-3074&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-3074&client=summon |